KSU establishes translational and comparative oncology research centerJanuary 24, 2018The Kansas State University College of Veterinary Medicine's new Center of Excellence for Translational and Comparative Oncology Research (CETCOR) focuses on improving the diagnosis, management, and treatment of both human and animal cancers. CETCOR was established in late 2017 through start-up funding from the university's Johnson Cancer Research Center and support from the College of Veterinary Medicine. "The overriding objective of CETCOR is to expedite the pre-clinical and clinical development, production and/or licensure of novel or improved medical interventions—drugs, immunotherapeutics and medical devices—for the treatment, diagnosis and monitoring of both human and animal cancers," said Raelene Wouda, BVSc, DACVIM (Oncology), MANZCVS (SAIM), assistant professor of oncology in the college's clinical sciences department. One unique aspect of CETCOR is that it does not focus on a single type of cancer or the development of a single novel drug or technology, said Dr. Wouda. "Our group aims to facilitate the advancement of all cancer-associated research taking place on campus and within the wider K-State community, whether that be at the basic physiologic and pharmacologic level or in the later stages of the therapeutic drug development pathway," Wouda said. CETCOR's primary mission is to advance discoveries by university faculty and …
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
Animal Cancer Foundation receives $1 million for canine cancer genome projectNovember 8, 2017 The Animal Cancer Foundation (ACF), a national nonprofit organization that supports comparative oncology research that studies the similarities between cancers in people and pets to help find cures for both, has received a $1 million dollar donation from the Blue Buffalo Foundation. The grant will provide funding for the Canine Cancer Genome Project (CCGP), which will map the tumor genomes of the most common canine cancers. Understanding the genetic makeup of canine cancer tumors, and comparing their genetic makeup to those of people with cancer, will allow researchers to discover additional targeted drug therapies and the least toxic doses of those therapies that are most effective in curing the individual, whether canine or human, according to ACF. The initiative arose as a result of a review conducted in 2015 by the Institute of Medicine of the National Academy of Science and supported in part by ACF that highlighted the value of comparative oncology and the inclusion of veterinary oncologists in accelerating cancer drug development. ACF has pledged to raise an additional $1 million dollars in support of the CCGP. The fundraising effort is supported by Blue Buffalo Foundation, which has partnered with …
